RT Journal Article
T1 Stereoselective Formation of Chiral Metallopeptides
A1 Rama, Gustavo
A1 Ardá, Ana
A1 Maréchal, Jean-Didier
A1 Gamba, Ilaria
A1 Ishida, Hitoshi
A1 Jiménez Barbero, Jesús
A1 Vázquez Sentís, Marco Eugenio
A1 Vázquez López, Miguel
K1 Chirality
K1 Ligand effects
K1 Metallopeptides
K1 Molecular modeling
K1 NMR spectroscopy
K1 Peptides
AB Playing into our hands: The achiral bipyridine amino acid fluorenylmethyloxycarbonyl 5‐amino‐3‐oxapentanoic acid (Fmoc‐O1PenBpy‐OH) has been used for the solid‐phase synthesis of metallopeptides. Circular dichroism, molecular modeling, and NMR spectroscopic studies show that the chirality of the resulting metal complexes in aqueous solution is determined, and can thus be controlled, by the stereochemistry of one proline residue in the loop between the two coordinating O1PenBpy residues
PB Wiley
YR 2012
FD 2012-05-03
LK http://hdl.handle.net/10347/17008
UL http://hdl.handle.net/10347/17008
LA eng
NO Rama, G., Ardá, A. , Maréchal, J., Gamba, I., Ishida, H., Jiménez‐Barbero, J., Vázquez, M. E. and Vázquez López, M. (2012), Stereoselective Formation of Chiral Metallopeptides. Chem. Eur. J., 18: 7030-7035. doi:10.1002/chem.201201036
NO This is the peer reviewed version of the following article: Rama, G., Ardá, A., Maréchal, J., Gamba, I., Ishida, H., Jiménez‐Barbero, J., Vázquez, M. E. and Vázquez López, M. (2012), Stereoselective Formation of Chiral Metallopeptides. Chem. Eur. J., 18: 7030-7035, which has been published in final form at https://doi.org/10.1002/chem.201201036.  This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Use of Self-Archived Versions
NO Consolider Ingenio. Grant Number: CSD2007‐00006Xunta de Galicia. Grant Numbers: INCITE09 209 084PR, GRC2010/12, PGIDIT08CSA‐047209PRPRESTO Program of JSTGrant‐in‐Aid for Scientific Research (C) from the Ministry of Education, Culture, Sports, Science, and Technology. Grant Number: 21550163International Iberian Nanotechnology Laboratory (INL)
DS Minerva
RD 25 abr 2026